advertisement

EVToday Banner

July 2009


In This Issue:
Next-Generation DES Technology

A look at how advances in stent therapy will supplant the current standard.

CHIEF MEDICAL EDITOR'S PAGE Next-Generation DES Technology By Ted E. Feldman, MD, FSCAI - Chief Medical Editor

NEW TECHNOLOGY Forward-Looking IVUS in Chronic Total Occlusions A new approach to an old problem. By Jason H. Rogers, MD

TECHNIQUES Rotational Ablation as a Bailout Technique How to facilitate expansion of a severely underexpanded stent. By David J. James, md; S. Chiu Wong, MD; and Issam D. Moussa, MD

COVER STORY The Perfect Drug-Eluting Stent Goals for stent, polymer, and drug development. By Tim A. Fischell, MD, FACC, FSCAI; Dwight Dishmon, MD; Adam Elhaddi, MD; Shadwan Alsafwah, MD; and Santhosh R. Mannem, MD

Nonstent Drug Delivery Current data on the use of drug-eluting balloon angioplasty to treat atherosclerotic arterial disease are limited but hold promise. By Verghese Mathew, MD, FACC

Metallic Stents Coated With Bioabsorbable Polymers An overview of polymer technology as a drug-carrier mechanism. By Wei Fan; Dave M. Johnson, Phd; and Marc D. Feldman, MD, FACC

Bioabsorbable Stents: The Future Is Near A review of the breakthroughs and challenges of bioabsorbable stents as a potential solution to the risks associated with available drug-eluting stents. By Refat Jabara, MD, FACC; Lakshmana Pendyala, MD; Jack Chen, MD, FACC; and Nicolas Chronos, MD, FACC

Drug-Eluting Stents Chart

FEATURED TECHNOLOGY Special Report: New Treatment for Refractory Angina: Robotic-Assisted TMR By Geoffrey Answini, MD, and Averel Snyder, MD

Innovations

An Interview With Lowell Satler, MD Dr. Satler discusses his facility at the Washington Cardiology Center and their role in ushering in new treatments, devices, and education, specifically for treating structural heart disease.